AbCellera Biologics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for AbCellera Biologics stock have an average target of 7.00, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 215.32% from the current stock price of 2.22.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$7.00	$10	$10
Change	+80.18%	+215.32%	+350.45%	+350.45%

* Price targets were last updated on Feb 28, 2025.

Analyst Ratings

The average analyst rating for AbCellera Biologics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Wasserman Benchmark	Benchmark	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 3, 2025
Stephen Willey Stifel	Stifel	Strong Buy Maintains $12 → $10	Strong Buy	Maintains	$12 → $10	+350.45%	Feb 28, 2025
Scott Schoenhaus Keybanc	Keybanc	Buy Maintains $5 → $4	Buy	Maintains	$5 → $4	+80.18%	Jan 8, 2025
Robert Wasserman Benchmark	Benchmark	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 5, 2024
Stephen Willey Stifel	Stifel	Strong Buy Reiterates $14 → $12	Strong Buy	Reiterates	$14 → $12	+440.54%	Nov 5, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

27.48M

from 28.83M

-4.68%

from 28.83M

Revenue Next Year

35.12M

from 27.48M

27.77%

from 27.48M

EPS This Year

-0.63

from -0.55

EPS Next Year

-0.66

from -0.63

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	233.16M	375.20M	485.42M	38.03M	28.83M	27.48M	35.12M	54.67M
Revenue Growth	1,907.88%	60.92%	29.38%	-92.17%	-24.17%	-4.68%	27.77%	55.67%
EPS	0.45	0.48	0.50	-0.51	-0.55	-0.63	-0.66	-0.81
EPS Growth	-	6.21%	4.17%	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	10	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	52.5M	63.0M	72.5M
Avg	27.5M	35.1M	54.7M
Low	17.4M	14.5M	37.4M

Revenue Growth

Revenue Growth	2025	2026	2027
High	82.1%	129.2%	106.3%
Avg	-4.7%	27.8%	55.7%
Low	-39.5%	-47.2%	6.6%

EPS Forecast

EPS	2025	2026	2027
High	-0.48	-0.48	-0.79
Avg	-0.63	-0.66	-0.81
Low	-0.72	-0.76	-0.82

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.